Follow
antonio cuadrado pastor
antonio cuadrado pastor
Department of Biochemistry. Medical College. Autonomous University of Madrid (UAM)
Verified email at uam.es
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13103*2021
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
A Cuadrado, AI Rojo, G Wells, JD Hayes, SP Cousin, WL Rumsey, ...
Nature reviews Drug discovery 18 (4), 295-317, 2019
9552019
Clinical relevance of biomarkers of oxidative stress
J Frijhoff, PG Winyard, N Zarkovic, SS Davies, R Stocker, D Cheng, ...
Antioxidants & redox signaling 23 (14), 1144-1170, 2015
8542015
Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical†…
D Martin, AI Rojo, M Salinas, R Diaz, G Gallardo, J Alam, ...
Journal of Biological Chemistry 279 (10), 8919-8929, 2004
8212004
SCF/‚-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner
P Rada, AI Rojo, S Chowdhry, M McMahon, JD Hayes, A Cuadrado
Molecular and cellular biology, 2011
7852011
Nrf2 is controlled by two distinct ‚-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
S Chowdhry, Y Zhang, M McMahon, C Sutherland, A Cuadrado, ...
Oncogene 32 (32), 3765-3781, 2013
6392013
The transcription factor Nrf2 is a therapeutic target against brain inflammation
NG Innamorato, AI Rojo, AJ García-Yagüe, M Yamamoto, ...
The Journal of Immunology 181 (1), 680-689, 2008
5432008
Glycogen synthase kinase-3‚ inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
M Salazar, AI Rojo, D Velasco, RM de Sagarra, A Cuadrado
Journal of Biological Chemistry 281 (21), 14841-14851, 2006
5352006
Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach
A Cuadrado, G Manda, A Hassan, MJ Alcaraz, C Barbas, A Daiber, ...
Pharmacological reviews 70 (2), 348-383, 2018
5342018
Activators and inhibitors of NRF2: a review of their potential for clinical development
N Robledinos-Antón, R Fernández-Ginés, G Manda, A Cuadrado
Oxidative medicine and cellular longevity 2019, 2019
4742019
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease
AM Martín-Moreno, D Reigada, BG Ramírez, R Mechoulam, N Innamorato, ...
Molecular pharmacology 79 (6), 964-973, 2011
4122011
Activation of Akt/Protein Kinase B by G protein-coupled receptors: a role for Š and ‚„ subunits of heterotrimeric g proteins acting through phosphatidylinositol-3-OH kinase„
C Murga, L Laguinge, R Wetzker, A Cuadrado, JS Gutkind
Journal of Biological Chemistry 273 (30), 19080-19085, 1998
4041998
Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
AI Rojo, NG Innamorato, AM Martín‐Moreno, ML De Ceballos, ...
Glia 58 (5), 588-598, 2010
3772010
Inflammation in ParkinsonĘs disease: mechanisms and therapeutic implications
M Pajares, A I. Rojo, G Manda, L Boscá, A Cuadrado
Cells 9 (7), 1687, 2020
3712020
Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/‚-TrCP axis
P Rada, AI Rojo, N Evrard-Todeschi, NG Innamorato, A Cotte, T Jaworski, ...
Molecular and cellular biology 32 (17), 3486-3499, 2012
3522012
Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
M Pajares, N Jiménez-Moreno, ÁJ García-Yagüe, M Escoll, ...
Autophagy 12 (10), 1902-1916, 2016
3422016
Transcription factors NRF2 and NF-ÍB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation
A Cuadrado, Z Martín-Moldes, J Ye, I Lastres-Becker
Journal of Biological Chemistry 289 (22), 15244-15258, 2014
3232014
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism
A Jazwa, AI Rojo, NG Innamorato, M Hesse, J Fernández-Ruiz, ...
Antioxidants & redox signaling 14 (12), 2347-2360, 2011
3232011
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ...
Redox biology 13, 94-162, 2017
3142017
Redox control of microglial function: molecular mechanisms and functional significance
AI Rojo, G McBean, M Cindric, J Egea, MG López, P Rada, N Zarkovic, ...
Antioxidants & redox signaling 21 (12), 1766-1801, 2014
3122014
The system can't perform the operation now. Try again later.
Articles 1–20